We are pleased to invite you to Medicon Valley Alliance’s Good Morning Meeting on the theme Genome editing & RNAi challenges.
RNAi screening has made it possible to identify new genes, or gene networks involved in a wide variety of biological processes. CRISPR-Cas9-mediated genome editing methods have opened up new opportunities for assay development, screening and validation. Merck, as a leading provider of RNAi and CRISPR tools, continues to develop new strategies to improve genome-wide screening and validation. This seminar will describe and compare different screening methods.
Date: September 20th, 2016
Time: 8:30 – 10:30
Address: Arne Jacobsens Allé 15, 2300 Copenhagen S
Room: Ground floor
Program
08.30-09.00 Coffee and networking
09.00-10.00 Genome editing & RNAi challenges incl. Q&A
Topics will include:
- RNAi and Genome Editing Screening: why Merck?
- RNAi versus Genome Editing
- Pooled versus Arrayed Screening
- Merck shRNA and CRISPR formats:
– shRNA Libraries
– RISPR Libraries
10.00-10:30 Networking
Speaker
Nadia Guettari
Scientific Liaison Team Specialist
Genomics Target Discovery – Pharma & Emerging Biotech
Participation
For members: Free of charge
For non-members: Free of charge (please see our event policy for non-members participation)
Registration ends September 16th, 2016.
This Good Morning Meeting is in collaboration with Sigma-Aldrich part of Merck group
